High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy.
about
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathiesImmunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathiesImmunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathiesMonoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathyNeuromuscular complications of human immunodeficiency virus infection and antiretroviral therapyIntravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines.Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS).Treatment of chronic inflammatory demyelinating polyneuropathy.Peripheral neuropathy in cancer patients.EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.Successful treatment of IgM paraproteinaemic neuropathy with fludarabineA randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.Rituximab in the treatment of peripheral neuropathy associated with monoclonal gammopathy.Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study GroupHigh-dose intravenous human immunoglobulin in polymyositis resistant to treatment.Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases.Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.Pathogenesis and Treatment of Anti-MAG Neuropathy.Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies.Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin.Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease.Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance.Chronic immune-related demyelinating neuropathies.Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies.Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy.Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies.Paraproteinemic neuropathy.Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significance.Autoimmune reactions in patients with M-component and peripheral neuropathy
P2860
Q24197877-083D57FD-5F28-4B50-AB40-7F325F0E557AQ24243918-0A7B8766-C26D-4DE4-89B1-FA341C5871F0Q24250235-399BF7EF-7A61-4070-97E3-6408A61BD24DQ30234567-F5A932F5-EC48-4755-9C9C-788A8171D014Q33591756-3B9B4386-336E-42A9-B152-42A531C389D5Q33607809-39138442-4C6B-4BD0-A4BE-02B2347E0F5FQ33735202-5A03ABF0-B79E-4B71-B328-0252B913ABB5Q33748109-506783A4-57FD-401B-9D38-C0952DEC2359Q33762563-7866E599-1614-4E87-9F92-27068A579CE6Q33996087-5FE069ED-BE4E-4521-AAAF-482DF9232060Q34280846-BB29DC87-E61A-41A8-A037-9815C62C8B88Q34597256-729D2CA3-7298-4A35-8632-FD5E0AA7457AQ35451247-F1D93F8D-7199-4475-88B6-59C69B36AB39Q36316836-92476F09-C034-4D08-889F-DB0B4DAAFF86Q36607310-1BCA4BFA-6CFE-4A3C-AAC2-2C2DE0BF9A40Q36880650-5AB6F2A6-5B14-4370-BF89-9BCF505DFAF5Q36957220-1467D17A-8A80-4AB9-BC9F-1E1157B2990AQ37267516-2C54462A-AAA3-4362-BC2F-0BAC06F10BA7Q37433060-A999456B-9E05-41AF-B6B6-F4CD463C757BQ37788996-300E8480-F563-41DD-941D-EB9672C8B106Q38856824-F3FF7D1E-DE23-4DB0-9462-60625B54D2EEQ38971983-FD0A4354-D01F-4495-924D-E7FB1F60FFB7Q39153035-B51B7C62-BC28-4110-824D-0D29F3E2AFEDQ40722123-3527EF62-74DE-4114-8943-27CFF7F84F0AQ40746921-A7E87F6B-C744-4E59-8D24-747F8B25AB73Q40851119-3CD5E6CB-85A8-483F-86D1-397872C89E11Q40939580-F94E18B4-5A51-414D-A783-3D753A771461Q41270448-6F4320F4-6CD7-4E30-8ED8-D598DB0BAAF1Q41589701-9D1BBF66-25D8-4097-811A-88C685DB7D48Q41663659-1DC329B1-7935-4284-BC83-B8D58FCE6C2AQ50197158-82EBF631-6B7E-4575-8391-F03E4D63FAC2Q53791232-FB799BB0-4D20-4400-8DA1-D6905B935C0DQ53965800-77C5FF59-8D9C-4C29-8814-995DFCDDCDD6Q58456223-1ED33F03-1969-4BA6-8B73-4472B3A31DEA
P2860
High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
High-dose intravenous immunogl ...... ed with monoclonal gammopathy.
@en
High-dose intravenous immunogl ...... ed with monoclonal gammopathy.
@nl
type
label
High-dose intravenous immunogl ...... ed with monoclonal gammopathy.
@en
High-dose intravenous immunogl ...... ed with monoclonal gammopathy.
@nl
prefLabel
High-dose intravenous immunogl ...... ed with monoclonal gammopathy.
@en
High-dose intravenous immunogl ...... ed with monoclonal gammopathy.
@nl
P2093
P356
P1433
P1476
High-dose intravenous immunogl ...... ed with monoclonal gammopathy.
@en
P2093
P304
P356
10.1212/WNL.40.2.212
P407
P577
1990-02-01T00:00:00Z